| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.067 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |